Thanks to Allentown's Zzyxx Polymers, plastics recycling may never be the same
Zzyxx Polymers, an Allentown startup, is developing a novel plastic polymers manufacturing process for recycling.
Ed tech company Frontline grows with new products, financing and a bigger HQ
At the forefront of web-based tools for K-12 education, fast-growing Frontline Technologies is moving to Malvern, nearly doubling its space.
Make it to the Greater Philadelphia Manufacturing Summit
The Delaware Valley Industrial Resource Center (DVIRC) is hosting the Greater Philadelphia Manufacturing Summit�on Friday, October 3 to demonstrate and the vigor of this essential sector.
New robotic arms from Pittsburgh's RE2 reach for a range of markets
The reach of Pittsburgh�s RE2 continues to grow, both in terms of its business and its robotic manipulator arms.
AmerisourceBergen expands to Conshohocken; 185 jobs to follow
AmerisourceBergen, a global pharmaceutical services company, is expanding into a new location in Conshohocken and expects to create at least 185 new jobs over the next three years.
Ben Franklin invests $475,000 in five Central PA startups
Ben Franklin Technology Partners of Central and Northern PA is investing $475,000 in five high-tech startups.
Major solar system will power Urban Outfitters' new center
Urban Outfitters' huge new fulfillment center will feature the largest roof-mounted solar energy system in Pennsylvania and the seventh largest energy system in the state.
Spin-off StratisIS EMS opens another market for Philly's BuLogics
Philadelphia�s rapidly morphing BuLogics has spun off StratisIS EMS, a company that is already profitable, with a growing list of clients and strategic partners.
Exton's EMS opening an independent simulation center for healthcare training
Exton's Education Management Solutions (EMS) is preparing to open a state-of-the-art simulation training facility for medical personnel at its headquarters.
$35 million in capital is a breath of fresh air for Yardley's OptiNose
Yardley's OptiNose has received $35 million in new capital to continue development of its treatment for serious chronic nasal inflammatory diseases (CNID).